Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

PubWeight™: 6.31‹?› | Rank: Top 1%

🔗 View Article (PMID 2997922)

Published in Science on November 22, 1985

Authors

S Benn, R Rutledge, T Folks, J Gold, L Baker, J McCormick, P Feorino, P Piot, T Quinn, M Martin

Articles citing this

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70

Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A (1988) 10.77

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci U S A (1988) 7.74

Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol (1988) 6.76

Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52

The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08

Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A (1986) 5.18

Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol (1986) 5.05

Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol (1988) 4.96

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol (1992) 4.72

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A (1986) 4.43

Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32

Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61

A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol (1990) 3.33

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J Virol (1994) 2.96

Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol (1990) 2.88

Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol (1990) 2.72

Organ-specific selection of viral variants during chronic infection. J Exp Med (1988) 2.71

Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48

Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. J Virol (1987) 2.33

An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A (1988) 2.20

In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J Virol (1990) 2.03

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol (1988) 1.95

The avian retrovirus env gene family: molecular analysis of host range and antigenic variants. J Virol (1988) 1.83

Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences. Proc Natl Acad Sci U S A (1986) 1.61

Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin. J Virol (1990) 1.61

Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation. J Exp Med (1989) 1.59

Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells. J Virol (1991) 1.59

Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts. Proc Natl Acad Sci U S A (1991) 1.58

Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol (1987) 1.47

Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. J Clin Invest (1986) 1.43

Low fidelity of cell-free DNA synthesis by reverse transcriptase of human immunodeficiency virus. J Virol (1988) 1.42

Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A (1986) 1.40

Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med (2011) 1.36

Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J Virol (1991) 1.19

Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol (1987) 1.17

Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences. J Virol (2000) 1.11

Infection of rabbits with human immunodeficiency virus 1. A small animal model for acquired immunodeficiency syndrome. J Exp Med (1989) 1.08

Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J Virol (2006) 1.06

Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med (1992) 1.05

Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.03

Human immunodeficiency virus type 1 infection of neural xenografts. Proc Natl Acad Sci U S A (1992) 0.98

Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo. J Virol (2011) 0.97

Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert. J Virol (1996) 0.96

Infection of rabbit T-cell and macrophage lines with human immunodeficiency virus. Proc Natl Acad Sci U S A (1988) 0.93

Genomic diversity of the acquired immunodeficiency syndrome retroviruses is reflected in alteration of its translational products. Proc Natl Acad Sci U S A (1986) 0.92

Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. J Virol (2004) 0.92

Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer. J Virol (2001) 0.89

Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources. J Virol (1992) 0.88

Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc Natl Acad Sci U S A (1993) 0.88

Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. J Clin Invest (1993) 0.87

An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro. Proc Natl Acad Sci U S A (1999) 0.85

The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication. J Virol (1995) 0.84

Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders. Nucleic Acids Res (2010) 0.80

Differential expression of perforin in cytotoxic lymphocyte in HIV/AIDS patients of China. J Clin Immunol (2006) 0.79

Genomic diversity of the Avian leukosis virus subgroup J gp85 gene in different organs of an infected chicken. J Vet Sci (2016) 0.75

Articles by these authors

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

Analysis of variance for gene expression microarray data. J Comput Biol (2000) 16.28

DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science (1988) 13.46

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet (1989) 11.39

Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A (1985) 8.53

The HIV 'A' (sor) gene product is essential for virus infectivity. Nature (1987) 7.51

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05

Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52

Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain (2001) 6.49

Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96

How good are clinical MEDLINE searches? A comparative study of clinical end-user and librarian searches. Comput Biomed Res (1990) 5.95

AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88

A Polycomb-group gene regulates homeotic gene expression in Arabidopsis. Nature (1997) 5.65

Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44

Matriarchs as repositories of social knowledge in African elephants. Science (2001) 5.39

Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med (1994) 5.32

The right not to know HIV-test results. Lancet (1995) 5.16

Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92

Posttranscriptional selection of simian virus 40-specific RNA. J Virol (1975) 4.87

Insulin-gene sharing in sib pairs with insulin-dependent diabetes mellitus: no evidence for linkage. Am J Hum Genet (1988) 4.86

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68

Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med (1988) 4.55

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A (1986) 4.43

Validation of the United States' version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol (2000) 4.41

Selective trafficking of KNOTTED1 homeodomain protein and its mRNA through plasmodesmata. Science (1995) 4.40

Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect (1998) 4.39

Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet (1994) 4.38

Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 4.28

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst (1991) 4.24

High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA (1998) 3.81

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science (1986) 3.80

Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay. J Clin Microbiol (1990) 3.80

Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77

Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73

Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70

Glycogen storage disease in adults. Ann Intern Med (1994) 3.58

The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. AIDS (1989) 3.48

Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem (1994) 3.41

Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet (1985) 3.33

High levels of untreated distress and fatigue in cancer patients. Br J Cancer (2004) 3.15

Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol (1986) 3.12

Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet (2000) 3.10

Characteristics of human herpesvirus-6. J Infect Dis (1988) 3.02

Identification of Gardnerella (Haemophilus) vaginalis. J Clin Microbiol (1982) 2.96

The ecology of gonococcal plasmids. J Gen Microbiol (1979) 2.87

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80

Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology (1992) 2.71

ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol (1999) 2.71

Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows. Nature (2010) 2.71

Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum (2009) 2.69

Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clin Infect Dis (1993) 2.68

Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire. Lancet (1977) 2.65

Retrospective seroepidemiology of AIDS virus infection in Nairobi populations. J Infect Dis (1987) 2.63

Intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg (2004) 2.61

Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis (1979) 2.57

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science (1986) 2.57

Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis (1988) 2.56

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med (1989) 2.51

Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA (1986) 2.48

Detecting antibodies to human immunodeficiency virus in dried blood on filter papers. J Infect Dis (1987) 2.47

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47

Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

Partial trisomy 16p in an adolescent with autistic disorder and Tourette's syndrome. Am J Med Genet (1994) 2.40

Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid. Lancet (1978) 2.37

Emergency department sonography by emergency physicians. Am J Emerg Med (1989) 2.35

Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc (1999) 2.34

Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr (1998) 2.33

ICISS: an international classification of disease-9 based injury severity score. J Trauma (1996) 2.32

Intense superradiant x rays from a compact source using a nanocathode array and emittance exchange. Phys Rev Lett (2012) 2.32

A conceptual model of psychosomatic illness in children. Family organization and family therapy. Arch Gen Psychiatry (1975) 2.31

Antibiotic susceptibility of Neisseria gonorrhoeae strains from Europe and Africa. Antimicrob Agents Chemother (1979) 2.31

Gene dosage and suceptibility to insulin-dependent diabetes. Ann Hum Genet (1980) 2.29

Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J Immunol (1992) 2.29

Naturally occurring "Rochalimaea henselae" infection in domestic cat. Lancet (1992) 2.28

Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes. Science (1985) 2.28

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect (2008) 2.26

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26

Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22

Molecular analysis of the yellow locus of Drosophila. EMBO J (1986) 2.20

Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med (1988) 2.20

A population-based, multivariate analysis of the association between 911 access and per-capita county trauma death rates. Ann Emerg Med (1992) 2.19

Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. J Biol Chem (1985) 2.18

Declining trends in some sexually transmitted diseases in Belgium between 1983 and 1989. Genitourin Med (1991) 2.17

Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J (1997) 2.16

TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res (2010) 2.14

Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care (1999) 2.14

Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09

Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08

Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes (1979) 2.08

The international epidemiology of AIDS. Sci Am (1988) 2.08